Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Stephen Craig Weldon is active.

Publication


Featured researches published by Stephen Craig Weldon.


Biochimica et Biophysica Acta | 2009

Characterization of recombinant human acetyl-CoA carboxylase-2 steady-state kinetics.

Virendar K. Kaushik; Michael Kavana; Jessica M. Volz; Stephen Craig Weldon; Susan Hanrahan; Jian Xu; Shari L. Caplan; Brian K. Hubbard

Acetyl-CoA carboxylase (ACC) catalyzes the carboxylation of acetyl-CoA to form malonyl-CoA, a key metabolite in the fatty acid synthetic and oxidation pathways. The present study describes the steady-state kinetic analysis of a purified recombinant human form of the enzyme, namely ACC2, using a novel LC/MS/MS assay to directly measure malonyl-CoA formation. Four dimensional matrices, in which bicarbonate (HCO(3)(-)), ATP, acetyl-CoA, and citrate were varied, and global data fitting to appropriate steady-state equations were used to generate kinetic constants. Product inhibition studies support the notion that the enzyme proceeds through a hybrid (two-site) random Ter Ter mechanism, one that likely involves a two-step reaction at the biotin carboxylase domain. Citrate, a known activator of animal forms of ACC, activates both by increasing k(cat) and k(cat)/K(M) for ATP and acetyl-CoA.


Analytical Biochemistry | 2004

Advanced glycation end product ligands for the receptor for advanced glycation end products: Biochemical characterization and formation kinetics

Jessica Valencia; Stephen Craig Weldon; Douglas Quinn; Geesje H. Kiers; Jeroen DeGroot; J.M. TeKoppele; Thomas Edward Hughes


Journal of Medicinal Chemistry | 2002

1-[2-[(5-Cyanopyridin-2-yl)amino]ethylamino]acetyl-2-(S)-pyrrolidinecarbonitrile: A Potent, Selective, and Orally Bioavailable Dipeptidyl Peptidase IV Inhibitor with Antihyperglycemic Properties

Edwin Bernard Villhauer; John A. Brinkman; Goli B. Naderi; Beth E. Dunning; Bonnie L. Mangold; Manisha Mone; Mary E. Russell; Stephen Craig Weldon; Thomas Edward Hughes


Biochemistry | 1999

NVP-DPP728 (1-[[[2-[(5-Cyanopyridin-2-yl)amino]ethyl]amino]acetyl]-2-cyano-(S)-pyrrolidine), a Slow-Binding Inhibitor of Dipeptidyl Peptidase IV

Thomas Edward Hughes; Manisha Mone; Mary E. Russell; Stephen Craig Weldon; Edwin Bernard Villhauer


Archive | 2012

Dual function proteins for treating metabolic disorders

Brian R. Boettcher; Shari L. Caplan; Susan E. Cellitti; Douglas S. Daniels; Norio Hamamatsu; Bernhard H. Geierstanger; Stuart Licht; Andreas Loew; Stephen Craig Weldon


Archive | 2012

Fusion proteins for treating metabolic disorders

Brian R. Boettcher; Shari L. Caplan; Douglas S. Daniels; Norio Hamamatsu; Stuart Licht; Stephen Craig Weldon


Archive | 2011

Methods of treating FGF21-associated disorders

Brian R. Boettcher; Shari L. Caplan; Douglas S. Daniels; Bernhard H. Geierstanger; Norio Hamamatsu; Stuart Licht; Andreas Loew; Stephen Craig Weldon


Archive | 2012

Fibroblast growth factor-21-Fc fusion proteins

Brian R. Boettcher; Shari L. Caplan; Douglas S. Daniels; Norio Hamamatsu; Stuart Licht; Stephen Craig Weldon


Archive | 2011

Fibroblast growth factor 21 mutations

Brian R. Boettcher; Shari L. Caplan; Douglas S. Daniels; Bernhard H. Geierstanger; Norio Hamamatsu; Stuart Licht; Andreas Loew; Stephen Craig Weldon


Archive | 2015

Methods of treating metabolic disorders with an FGF21 variant

Brian R. Boettcher; Shari L. Caplan; Douglas S. Daniels; Norio Hamamatsu; Stuart Licht; Stephen Craig Weldon

Collaboration


Dive into the Stephen Craig Weldon's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Bernhard H. Geierstanger

Genomics Institute of the Novartis Research Foundation

View shared research outputs
Top Co-Authors

Avatar

Susan E. Cellitti

Genomics Institute of the Novartis Research Foundation

View shared research outputs
Researchain Logo
Decentralizing Knowledge